Advanced Enzyme Technologies Limited (NSE: ADVENZYMES)

Market Cap	51.02B
Revenue (ttm)	6.31B
Net Income (ttm)	1.39B
Shares Out	111.82M
EPS (ttm)	12.39
PE Ratio	36.83
Forward PE	28.52
Dividend	5.10 (1.12%)
Ex-Dividend Date	Jul 18, 2024

Volume	173,615
Open	464.70
Previous Close	463.85
Day's Range	452.70 - 469.70
52-Week Range	291.10 - 486.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About ADVENZYMES

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specia...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1957
• Employees: 323
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ADVENZYMES

Financial Performance

In 2023, ADVENZYMES's revenue was 6.24 billion, an increase of 15.39% compared to the previous year's 5.41 billion. Earnings were 1.33 billion, an increase of 26.19%.